Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trial
Jurriaan B Tuynman(Amsterdam University Medical Centers), Aaldert K. Talsma(Deventer Ziekenhuis), Wytze Laméris, Francisco B. de Lacy(Hospital Quirónsalud Barcelona), L. Mol, T. W. A. Koedam, Jan-Hein T. M. van Waesberghe(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jaap Bonjer, Antonio de Lacy(Hospital Quirónsalud Barcelona), Hein B A C Stockmann(Spaarne Ziekenhuis), Charlotte Deijen, Hendrik J Bonjer(Amsterdam University Medical Centers), Annabel van Lieshout, George B Hanna(Imperial College London), Antonio Caycedo–Marulanda(Orlando Health), Michał Pędziwiatr(Jagiellonian University), Jos W R Twisk(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 4
Related Papers
Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting
|Annals of Surgical Oncology|2023|13
Limited wedge resection for T1 colon cancer (LIMERIC-II trial) – rationale and study protocol of a prospective multicenter clinical trial
|BMC Gastroenterology|2023|8
ASO Visual Abstract: Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting
|Annals of Surgical Oncology|2023|2
Correction: Limited wedge resection for T1 colon cancer (LIMERIC-II trial) – rationale and study protocol of a prospective multicenter clinical trial
|BMC Gastroenterology|2023|1
Hospital costs of different treatment strategies for anastomotic leakage after total mesorectal excision: a multicentre cost analysis
|Techniques in Coloproctology|2025|0